secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK:        0001100682
Form:       8-K
Filed at:   2025-12-03T23:59:59+00:00
Accession:  0001628280-25-054902
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Charles River Labs reports improving DSA book-to-bill trends, encouraged by momentum since mid-2025
--------------------------------------------------------------------------------

- DSA net book-to-bill has improved each month since Q3 2025 started.
- Management cites positive momentum and upward trends from mid-2025 onward.
- Seasonality around holidays and early January may affect near-term proposal and booking activity.
- Update provided at Evercore 8th Annual Healthcare Conference on December 3, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100682/000162828025054902/0001628280-25-054902-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100682/000162828025054902/crl-20251203.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-054902

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer